Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature

Proliferative glomerulonephritis with monoclonal immunoglobulin IgG deposits (PGNMID) is an already described form of renal involvement by monoclonal gammopathy. PGNMID is known to recur in kidney allografts. Bortezomib has shown clinical success in the treatment of multiple myeloma. However, its ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, Rikako, Unagami, Kohei, Taneda, Sekiko, Takagi, Toshio, Ishida, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107408/
https://www.ncbi.nlm.nih.gov/pubmed/35522429
http://dx.doi.org/10.1007/s40620-022-01332-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107408/
https://www.ncbi.nlm.nih.gov/pubmed/35522429
http://dx.doi.org/10.1007/s40620-022-01332-x

Ejemplares similares